/
Phreesia, Inc. ("Phreesia," "we," "our," or the "Company") was founded in 2005 and completed its initial public offering in July 2019. Phreesia provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes.
The business is unprofitable at the operating level (-1.38% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 14.5% YoY with margins expanding 12.5pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$496M
▲ +14.5% YoY
Net Income (TTM)
$9M
▲ +103.9% YoY
Op. Margin
0.69%
▲ +12.5pp YoY
ROIC
0.78%
▲ +14.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$76M
▲ +186.0% YoY
Op. Cash Flow (TTM)
$88M
▲ +143.4% YoY
Net Debt
-$63M
Net Cash Position
Cash & Equiv.
$76M
5Y CAGR: +26.4%
Continue Research